Article written

SA: Less funds will cause unnecessary AIDS deaths 0

JOHANNESBURG – Backtracking by international donors in funding the fight against HIV/AIDS risks widening the treatment gap in Africa, undermining years of positive achievements in the field, warns a new Medecins Sans Frontières report. And many more unnecessary HIV-related deaths will be caused by these shifts in international donor funding.

Released at the end of May, the report is titled “No time to quit“. And its author, Mit Philips, is extremely worried. Success in the fight against HIV/AIDS is very fragile, she believes.

“How can we give up the fight halfway and pretend that the crisis is over? Nine million people worldwide in need of urgent treatment still lack access to this life-saving care… There is a real risk that many of them will die within the next few years if necessary steps are not taken now,” said Philips.

The flat lining of annual budget allocations for HIV/AIDS, alongside the reduction of the number of donor organisations funding HIV/AIDS treatment in the most affected countries places increasing pressure on already under-resourced health systems.

HIV/AIDS is no longer treated as an emergency.

Philips wonders whether speaking too much about success and not enough about the work still to be done has resulted in decreasing public pressure in Europe and the U.S. “In Europe, HIV has become a very treatable chronic disease. It’s hard for people to imagine that it has such a different face in Africa. It’s two different worlds,” Philips said.

Two thirds of people living with HIV in sub-Saharan Africa that need treatment – some six million people – are not getting it. Stock outs in some countries of life-saving anti-retroviral treatment, as well as doubts about future funding have far-reaching consequences for health systems planning, and especially implications for ARV programmes.

The financial crisis and changing approaches to the fight against the disease have resulted in a re-categorisation of funding, away from providing treatment to once-off injections of equipment or infrastructure, thereby avoiding recurrent costs. But those who are already on treatment need the funding to continue for them to be able to receive their medication. And those not on treatment will not be able to access it, unless funding is not only maintained, but increased.

Mark Heywood, deputy chairperson of the South African National AIDS Council believes the issue for South Africa is not about sustaining existing levels of funding, but increasing donor support in order to allow treatment to be scaled up. Currently the country has some one million people on anti-retroviral treatment, but in the next five years, the number will need to rise to approximately five million. This expansion is not something South Africa can afford to fund on its own.

Although the South African government depends less on international donors than some of its neighbours, healthcare is still underfunded.

“But this doesn’t make South Africa a beggar for international charity,” said Heywood. “What it does make clear is that managing the epidemic is an international responsibility. Health is a global duty.”

Continue reading on IPS

By Nastasya TayIPS

Download the full MSF report No time to quit – pdf version

subscribe to comments RSS

There are no comments for this post

Please, feel free to post your own comment

* these are required fields

P.IVA 11273390150
Direttore Responsabile Giuseppe Frangi